ArticleFrontiers in psychology2026
Sense of agency and decision making.
Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Agency is the sense that one has control over one's own actions and the consequences of those actions. A recent theory proposes that increases in agency disinhibit the dopamine system and thereby increase the number of tonically active dopamine neurons in the ventral tegmental area. The theory, called ADDS (Agency Disinhibits the Dopamine System), proposes a specific neural network that mediates these effects. ADDS successfully accounts for a variety of relevant neuroscience and behavioral results. This article extends ADDS to decision making by deriving many novel predictions about how the sense of agency affects many different components of the decision-making process. Specifically, it is shown that ADDS predicts that increases in agency should: 1) increase the value of positive outcomes but have relatively little effect on the value of negative outcomes; 2) increase risk taking; and 3) reduce temporal discounting, except in cases where endogenous DA levels are unusually high, in which case increases in agency should increase temporal discounting. More empirical work is needed to test these predictions rigorously. Even so, considerable existing evidence is reviewed that supports each of these predictions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.